Västra Hamnen Market Focus Feed

2025-11-14 10:30:00 Crunchfish: Laying the foundation

2025-11-12 10:15:00 Xintela: Focus on study results and financing

2025-10-31 09:30:00 USWE Sports: Vinner mark trots osäkerhet i USA

2025-10-24 15:01:00 ProstaLund: Sista rapporten som noterat bolag

2025-10-21 10:30:00 Bioextrax: Which would you like to hear first?

2025-09-05 11:00:00 Xintela: Awaiting final follow-up data

2025-09-05 08:30:00 aXichem: Försäljningstillväxt i prognosen

2025-09-02 12:46:00 ProstaLund: Beslut om avnotering

2025-09-01 13:00:00 Lipum: Finding financial support

2025-09-01 12:00:00 Gabather: TOTEMS-study delayed, not derailed

2025-08-28 12:05:00 Bioextrax: Still awaiting the potential to materialise

2025-08-25 15:00:00 Crunchfish: Episode III: A New Hope

2025-08-19 16:30:00 Precise Biometrics: Market uncertainty slows Q2

2025-08-01 15:30:00 USWE Sports: Ökad omsättning i osäker omvärld

2025-06-19 10:25:00 Gabather: High potential in specific modulation

2025-06-05 14:05:00 Crunchfish’s CEO on new approach

2025-06-03 08:35:00 USWE Sports: Framåtriktat avslut av 2024/25

2025-06-02 15:20:00 Xintela: Taking position for the next phase

2025-06-02 14:45:00 ProstaLund: Räddningsplanka hävde konkurshot

2025-05-26 12:15:00 Crunchfish: Awaiting progress in India

2025-05-23 16:00:00 aXichem: Lovande start på 2025

2025-05-22 14:15:00 Bioextrax: An exciting summer ahead

2025-05-16 16:00:00 Precise Biometrics: Headwind in Q1

2025-05-06 11:15:00 Xintela: Licensing deal with EQGen Biomedical

2025-04-28 12:40:00 Lipum: Focusing on financing phase II

2025-03-28 08:33:00 Xintela: Promising data for XSTEM in OA

2025-03-07 13:34:00 Xintela: Interim phase I/IIa data coming up

2025-03-05 10:35:00 Lipum: A busy year ahead

2025-03-04 13:59:00 aXichem: Framsteg i Brasilien och motvind i EU

2025-02-27 13:30:00 Bioextrax: Materialising opportunities

2025-02-24 15:01:00 ProstaLund: Fokus på försäljningstillväxt

2025-02-18 12:57:00 Crunchfish: 2025 – time to deliver

2025-02-18 08:30:00 Precise Biometrics: Scanning for higher growth

2025-02-14 09:21:00 CombiGene: Making place for new ventures

2025-01-31 17:30:00 USWE Sports: På rätt spår, men mer fart behövs

2025-01-28 14:06:00 ProstaLund: Studie visar fördelar med CoreTherm

2024-12-06 11:18:00 Bioextrax: High interest and steady progress

2024-12-04 15:15:00 Crunchfish: Awaiting commercial break-through

2024-12-03 10:49:00 aXichem: Studie- och testresultat kring årsskiftet

2024-11-28 12:45:00 Xintela: Flerie provides short-term funding

2024-11-28 10:50:00 Medimi: Fokus på Danmark efter uteblivet förvärv

2024-11-22 15:30:00 USWE Sports: Positionerade för tillväxt

2024-11-11 13:38:00 CombiGene: Strategic consequences after CG01

2024-11-11 12:20:00 ProstaLund: CoreTherm Eagle flygfärdig

2024-11-01 09:57:00 CombiGenes vd om de senaste strategiska besluten

2024-10-29 16:15:00 CombiGene: New priorities after strategic decision

2024-10-29 15:00:00 Lipum: Progress towards the next phase

2024-09-20 15:30:00 Intervju med Lipums vd Ola Sandborgh

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Västra Hamnen Market Focus

Prenumeration

Vem äger bolaget?

Västra Hamnen Market Focus

Prenumeration

Vem äger bolaget?

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden